155 related articles for article (PubMed ID: 36715742)
1. Adverse events associated with pessary use over one year among women attending a pessary care clinic.
Kakkar A; Reuveni-Salzman A; Bentaleb J; Belzile E; Merovitz L; Larouche M
Int Urogynecol J; 2023 Aug; 34(8):1765-1770. PubMed ID: 36715742
[TBL] [Abstract][Full Text] [Related]
2. Pessaries (mechanical devices) for managing pelvic organ prolapse in women.
Bugge C; Adams EJ; Gopinath D; Stewart F; Dembinsky M; Sobiesuo P; Kearney R
Cochrane Database Syst Rev; 2020 Nov; 11(11):CD004010. PubMed ID: 33207004
[TBL] [Abstract][Full Text] [Related]
3. Ring and Gellhorn pessaries used in patients with pelvic organ prolapse: a retrospective study of 8 years.
Yang J; Han J; Zhu F; Wang Y
Arch Gynecol Obstet; 2018 Sep; 298(3):623-629. PubMed ID: 29978415
[TBL] [Abstract][Full Text] [Related]
4. Discontinuation rate and adverse events after 1 year of vaginal pessary use in women with pelvic organ prolapse.
Yimphong T; Temtanakitpaisan T; Buppasiri P; Chongsomchai C; Kanchaiyaphum S
Int Urogynecol J; 2018 Aug; 29(8):1123-1128. PubMed ID: 28815277
[TBL] [Abstract][Full Text] [Related]
5. Long-term adherence to pessary use in women with pelvic organ prolapse: A retrospective cohort study.
Koch M; Carlin G; Lange S; Umek W; Krall C; Bodner-Adler B
Maturitas; 2023 Dec; 178():107828. PubMed ID: 37659128
[TBL] [Abstract][Full Text] [Related]
6. Long-term continuations rate of ring pessary use for symptomatic pelvic organ prolapse.
Manchana T
Arch Gynecol Obstet; 2024 May; 309(5):2203-2209. PubMed ID: 38189963
[TBL] [Abstract][Full Text] [Related]
7. Ring pessary for all pelvic organ prolapse.
Manchana T
Arch Gynecol Obstet; 2011 Aug; 284(2):391-5. PubMed ID: 20848116
[TBL] [Abstract][Full Text] [Related]
8. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse.
Mao M; Ai F; Kang J; Zhang Y; Liang S; Zhou Y; Zhu L
Menopause; 2019 Feb; 26(2):145-151. PubMed ID: 30130292
[TBL] [Abstract][Full Text] [Related]
9. Successful use of the Gellhorn pessary as a second-line pessary in women with advanced pelvic organ prolapse.
Deng M; Ding J; Ai F; Zhu L
Menopause; 2017 Nov; 24(11):1277-1281. PubMed ID: 28640155
[TBL] [Abstract][Full Text] [Related]
10. Pessary types and discontinuation rates in patients with advanced pelvic organ prolapse.
Wolff B; Williams K; Winkler A; Lind L; Shalom D
Int Urogynecol J; 2017 Jul; 28(7):993-997. PubMed ID: 27942793
[TBL] [Abstract][Full Text] [Related]
11. A tailored flexible vaginal pessary treatment for pelvic organ prolapse in older women.
Gold RS; Baruch Y; Amir H; Gordon D; Groutz A
J Am Geriatr Soc; 2021 Sep; 69(9):2518-2523. PubMed ID: 33979457
[TBL] [Abstract][Full Text] [Related]
12. Effect of vaginal estrogen on pessary use.
Dessie SG; Armstrong K; Modest AM; Hacker MR; Hota LS
Int Urogynecol J; 2016 Sep; 27(9):1423-9. PubMed ID: 26992727
[TBL] [Abstract][Full Text] [Related]
13. Long-term Outcomes of Self-Management Gellhorn Pessary for Symptomatic Pelvic Organ Prolapse.
Chien CW; Lo TS; Tseng LH; Lin YH; Hsieh WC; Lee SJ
Female Pelvic Med Reconstr Surg; 2020 Nov; 26(11):e47-e53. PubMed ID: 31393340
[TBL] [Abstract][Full Text] [Related]
14. Factors Affecting Successfulness of Vaginal Pessary Use for the Treatment of Pelvic Organ Prolapse.
Lekskulchai O; Wanichsetakul P
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S115-20. PubMed ID: 26387398
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with pessary fitting in women with symptomatic pelvic organ prolapse: A large prospective cohort study.
Ma C; Xu T; Kang J; Zhang Y; Ma Y; Liang S; Zhu L
Neurourol Urodyn; 2020 Nov; 39(8):2238-2245. PubMed ID: 32936968
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of a continuous-use ring-shaped vaginal pessary without support for advanced pelvic organ prolapse in postmenopausal women.
Dueñas JL; Miceli A
Int Urogynecol J; 2018 Nov; 29(11):1629-1636. PubMed ID: 29478114
[TBL] [Abstract][Full Text] [Related]
17. The usage of Gellhorn pessary in pelvic organ prolapse and in regards to success, continuity of use and effect on symptoms: a retrospective study of 2 years.
Ramanujam S; Balakrishnan S
Med J Malaysia; 2023 Nov; 78(6):705-710. PubMed ID: 38031210
[TBL] [Abstract][Full Text] [Related]
18. Natural history of pessary use in women aged 65 - 74 versus 75 years and older with pelvic organ prolapse: a 12-year study.
Ramsay S; Tu le M; Tannenbaum C
Int Urogynecol J; 2016 Aug; 27(8):1201-7. PubMed ID: 26872647
[TBL] [Abstract][Full Text] [Related]
19. [Clinical study on silicone pessary in the treatment of pelvic organ prolapse].
Yang JF; Han JS; Zhu FL; Wang YT; Yao Y; Qiao J
Zhonghua Fu Chan Ke Za Zhi; 2012 Jul; 47(7):487-91. PubMed ID: 23141156
[TBL] [Abstract][Full Text] [Related]
20. Does vaginal estrogen treatment with support pessaries in vaginal prolapse reduce complications?
Bulchandani S; Toozs-Hobson P; Verghese T; Latthe P
Post Reprod Health; 2015 Dec; 21(4):141-5. PubMed ID: 26537626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
